Clinical trial
The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease
NCT07182942 is registered in ClinicalTrials.gov with Chujin Cao as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease
- Lead sponsor
- Chujin Cao
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- June 7, 2024
- Completion date
- December 31, 2025
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ckd, drug effect